In vitro antifungal susceptibilities of Trichosporon species

doi:10.1128/AAC.46.4.1144-1146.2002

Comparative Study

. 2002 Apr;46(4):1144-6.

doi: 10.1128/AAC.46.4.1144-1146.2002.

In vitro antifungal susceptibilities of Trichosporon species

Niki I Paphitou¹, Luis Ostrosky-Zeichner, Victor L Paetznick, Jose R Rodriguez, Enuo Chen, John H Rex

Affiliations

Affiliation

¹ Laboratory for Mycology Research, Center for the Study of Emerging and Re-Emerging Pathogens, Division of Infectious Diseases, University of Texas-Houston Medical School, Houston, Texas 77030, USA. Elpida-Niki.I.Paphitou@uth.tmc.edu

PMID: 11897610
PMCID: PMC127118
DOI: 10.1128/AAC.46.4.1144-1146.2002

Comparative Study

In vitro antifungal susceptibilities of Trichosporon species

Niki I Paphitou et al. Antimicrob Agents Chemother. 2002 Apr.

. 2002 Apr;46(4):1144-6.

doi: 10.1128/AAC.46.4.1144-1146.2002.

Authors

Niki I Paphitou¹, Luis Ostrosky-Zeichner, Victor L Paetznick, Jose R Rodriguez, Enuo Chen, John H Rex

Affiliation

¹ Laboratory for Mycology Research, Center for the Study of Emerging and Re-Emerging Pathogens, Division of Infectious Diseases, University of Texas-Houston Medical School, Houston, Texas 77030, USA. Elpida-Niki.I.Paphitou@uth.tmc.edu

PMID: 11897610
PMCID: PMC127118
DOI: 10.1128/AAC.46.4.1144-1146.2002

Abstract

The in vitro activities of amphotericin B, itraconazole, fluconazole, voriconazole, posaconazole, and ravuconazole against 39 isolates of Trichosporon spp. were determined by the NCCLS M27-A microdilution method. The azoles tested appeared to be more potent than amphotericin B. Low minimal fungicidal concentration/MIC ratios were observed for voriconazole, posaconazole, and ravuconazole, suggesting fungicidal activity.

PubMed Disclaimer

Comment in

Multidrug-resistant Trichosporon asahii isolates are susceptible to voriconazole.
Falk R, Wolf DG, Shapiro M, Polacheck I. Falk R, et al. J Clin Microbiol. 2003 Feb;41(2):911. doi: 10.1128/JCM.41.2.911.2003. J Clin Microbiol. 2003. PMID: 12574315 Free PMC article. No abstract available.

Cited by

Epidemiological study of Trichosporon asahii infections over the past 23 years.
Li H, Guo M, Wang C, Li Y, Fernandez AM, Ferraro TN, Yang R, Chen Y. Li H, et al. Epidemiol Infect. 2020 Jul 24;148:e169. doi: 10.1017/S0950268820001624. Epidemiol Infect. 2020. PMID: 32703332 Free PMC article.
Head-to-head comparison of inhibitory and fungicidal activities of fluconazole, itraconazole, voriconazole, posaconazole, and isavuconazole against clinical isolates of Trichosporon asahii.
Hazirolan G, Canton E, Sahin S, Arikan-Akdagli S. Hazirolan G, et al. Antimicrob Agents Chemother. 2013 Oct;57(10):4841-7. doi: 10.1128/AAC.00850-13. Epub 2013 Jul 22. Antimicrob Agents Chemother. 2013. PMID: 23877683 Free PMC article.
Rare opportunistic (non-Candida, non-Cryptococcus) yeast bloodstream infections in patients with cancer.
Chitasombat MN, Kofteridis DP, Jiang Y, Tarrand J, Lewis RE, Kontoyiannis DP. Chitasombat MN, et al. J Infect. 2012 Jan;64(1):68-75. doi: 10.1016/j.jinf.2011.11.002. Epub 2011 Nov 11. J Infect. 2012. PMID: 22101079 Free PMC article.
The Prevalence and Risk Factors of Trichosporonosis at King Abdulaziz University Hospital.
Alboloshi GJ, Jiman-Fatani AA, Attallah D, Mokhtar JA, Al-Abdullah NA, Alkuwaity K, Kaki R, Al-Rabia MW, Alfadil A, Ibrahem K, Teklemariam AD, Harakeh S. Alboloshi GJ, et al. Int J Gen Med. 2024 Apr 3;17:1297-1310. doi: 10.2147/IJGM.S449511. eCollection 2024. Int J Gen Med. 2024. PMID: 38590998 Free PMC article.
Biofilm formation by the emerging fungal pathogen Trichosporon asahii: development, architecture, and antifungal resistance.
Di Bonaventura G, Pompilio A, Picciani C, Iezzi M, D'Antonio D, Piccolomini R. Di Bonaventura G, et al. Antimicrob Agents Chemother. 2006 Oct;50(10):3269-76. doi: 10.1128/AAC.00556-06. Antimicrob Agents Chemother. 2006. PMID: 17005804 Free PMC article.

See all "Cited by" articles

References

1. Anaissie, E., and G. P. Bodey. 1991. Disseminated trichosporonosis: meeting the challenge. Eur. J. Clin. Microbiol. Infect. Dis 10:711-713. - PubMed
1. Anaissie, E. J., G. P. Bodey, and M. G. Rinaldi. 1989. Emerging fungal pathogens. Eur. J. Clin. Microbiol. Infect. Dis 8:323-330. - PubMed
1. Cawley, M. J., G. R. Braxton, L. R. Haith, K. J. Reilly, R. E. Guilday, and M. L. Patton. 2000. Trichosporon beigelii infection: experience in a regional burn center. Burns 26:483-486. - PubMed
1. Ebright, J. R., M. R. Fairfax, and J. A. Vazquez. 2001. Trichosporon asahii, a non-candida yeast that caused fatal septic shock in a patient without cancer or neutropenia. Clin. Infect. Dis. 33:E28-E30. - PubMed
1. Espinel-Ingroff, A. 1998. Comparison of In vitro activities of the new triazole SCH56592 and the echinocandins MK-0991 (L-743,872) and LY303366 against opportunistic filamentous and dimorphic fungi and yeasts. J. Clin. Microbiol. 36:2950-2956. - PMC - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Miscellaneous
- NCI CPTAC Assay Portal

[1] Anaissie, E., and G. P. Bodey. 1991. Disseminated trichosporonosis: meeting the challenge. Eur. J. Clin. Microbiol. Infect. Dis 10:711-713. - PubMed

[2] Anaissie, E., and G. P. Bodey. 1991. Disseminated trichosporonosis: meeting the challenge. Eur. J. Clin. Microbiol. Infect. Dis 10:711-713. - PubMed

[3] Anaissie, E. J., G. P. Bodey, and M. G. Rinaldi. 1989. Emerging fungal pathogens. Eur. J. Clin. Microbiol. Infect. Dis 8:323-330. - PubMed

[4] Anaissie, E. J., G. P. Bodey, and M. G. Rinaldi. 1989. Emerging fungal pathogens. Eur. J. Clin. Microbiol. Infect. Dis 8:323-330. - PubMed

[5] Cawley, M. J., G. R. Braxton, L. R. Haith, K. J. Reilly, R. E. Guilday, and M. L. Patton. 2000. Trichosporon beigelii infection: experience in a regional burn center. Burns 26:483-486. - PubMed

[6] Cawley, M. J., G. R. Braxton, L. R. Haith, K. J. Reilly, R. E. Guilday, and M. L. Patton. 2000. Trichosporon beigelii infection: experience in a regional burn center. Burns 26:483-486. - PubMed

[7] Ebright, J. R., M. R. Fairfax, and J. A. Vazquez. 2001. Trichosporon asahii, a non-candida yeast that caused fatal septic shock in a patient without cancer or neutropenia. Clin. Infect. Dis. 33:E28-E30. - PubMed

[8] Ebright, J. R., M. R. Fairfax, and J. A. Vazquez. 2001. Trichosporon asahii, a non-candida yeast that caused fatal septic shock in a patient without cancer or neutropenia. Clin. Infect. Dis. 33:E28-E30. - PubMed

[9] Espinel-Ingroff, A. 1998. Comparison of In vitro activities of the new triazole SCH56592 and the echinocandins MK-0991 (L-743,872) and LY303366 against opportunistic filamentous and dimorphic fungi and yeasts. J. Clin. Microbiol. 36:2950-2956. - PMC - PubMed

[10] Espinel-Ingroff, A. 1998. Comparison of In vitro activities of the new triazole SCH56592 and the echinocandins MK-0991 (L-743,872) and LY303366 against opportunistic filamentous and dimorphic fungi and yeasts. J. Clin. Microbiol. 36:2950-2956. - PMC - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

In vitro antifungal susceptibilities of Trichosporon species

Affiliation

In vitro antifungal susceptibilities of Trichosporon species

Authors

Affiliation

Abstract

Comment in

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Miscellaneous

Abstract

Comment in

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

Related information

LinkOut - more resources

Full Text Sources

Miscellaneous